Article
Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.
Journal of chemotherapy (Florence, Italy) - 1 Aug 2006
De Azavedo J C S, Duncan C L, Kilburn L, Downar J, Kong B, Lad S, Low D E, Bast D J
Abstract excerpt
Serial passage of a clinical isolate of Streptococcus pneumoniae, in the presence of moxifloxacin, gatifloxacin or gemifloxacin, gave rise to resistant isolates. Non-susceptibility as defined by Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) breakpoints arose on Days 10, 11, and 12 with gatifloxacin, gemifloxacin, and moxifloxacin respectively. Moxifloxacin and gatifloxacin selected for a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
